BioSpace News Archive

Deals

DanDrit Signs Agreement to Acquire Enochian Biopharma

DanDrit plans to change its name to Enochian ImmunoScience and relocate to Los Angeles, California.

January 23, 2018
·
2 min read
Pharm Country

Merck Announces Second-Quarter 2018 Dividend

Merck today announced that the Board of Directors has declared a quarterly dividend of $0.48 per share of the company’s common stock for the second quarter of 2018.

January 23, 2018
·
3 min read
Business

JSR’s Life Sciences Division Appoints New CEO for MBL International

JSR Life Sciences, the life sciences-focused business unit of JSR Corporation, announced today that it has appointed Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International (MBLI) effective immediately.

January 23, 2018
·
2 min read
FDA

QIAGEN Wins FDA Nod for First-Ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms

The approval is for its ipsogen JAK2 RGQ PCR Kit for additional use in the diagnosis of all MPNs.

January 23, 2018
·
1 min read
Pharm Country

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

Rocket also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

January 23, 2018
·
5 min read
Genetown

Synlogic Announces Proposed Public Offering of Common Stock

Synlogic intends to grant the underwriters a 30-day option to purchase up to an aggregate of an additional 15% of the shares of its common stock offered in the public offering.

January 23, 2018
·
5 min read
Pharm Country

PAVmed Announces Closing of Firm Commitment Common Stock Offering

PAVmed announced underwritten public offering of 2,415,278 shares of its common stock at a public offering price of $1.80 per share.

January 23, 2018
·
4 min read
Biotech Beach

Aerie Pharmaceuticals Announces Public Offering of Common Stock

Aerie today announced that it has commenced a registered underwritten public offering of $75 million of shares of its common stock.

January 23, 2018
·
3 min read
Genetown

Ultivue Inc. Announces Completion of its Series B Financing

Ultivue Inc. announced today that it has closed a $20 million Series B funding round led by existing investor ARCH Venture Partners.

January 23, 2018
·
2 min read
Deals

Astellas Completes Acquisition of Mitobridge

By exercising the option right to acquire Mitobridge, Astellas paid $225M to acquire 100% of the equity in Mitobridge.

January 23, 2018
·
3 min read